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There still are many clinical and biological aspects of the natural history of cancer of the upper 
aerodigestive tract to be unveiled; which in Brazil is a direct consequence of the failure of systematic 
prevention and early diagnosis campaigns.
Objective: To analyze the signs and symptoms presented by patients with the disease at initial 
and advanced stages. Other variables such as disease duration, general and nutritional status were 
considered.
Method: A historical cohort study with a cross-section involving 895 subjects with cancer of the 
upper aerodigestive tract.
Results: Clinical findings were not statistically correlated with disease progression, nor with the 
disease in early stages, but it showed rapid disease development.
Conclusion: The results suggest a disease of insidious onset in the early stages and fast course 
afterwards. The long disease duration - greater than three months, was associated with worsening 
in general and nutritional states of patients.
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INTRODUCTION
Head and neck cancer is the sixth most pre-
valent primary malignant neoplasm in the world, 
accounting for 5% of all cancers in men and 2.5 % in 
women1, being epidemiologically important in many 
countries worldwide, including Brazil2,3.
The most affected anatomical site by head and 
neck cancer in the upper aerodigestive tract, distri-
buted among the oral cavity (35%-40%), oropharynx 
(30%), larynx (25%) and hypopharynx (7%)4. The 
most prevalent histological type of cancer located in 
the upper aerodigestive tract is the Squamous Cell 
Carcinoma (SCC) in 90% of the cases, and its main 
etiological factors are tobacco smoking and alcoho-
lic beverages drinking5-7, although infection by the 
human papilloma virus (HPV) has been responsible 
for at least 10% to 30% of oropharyngeal cancers8.
Clinical staging at the time of diagnosis is the 
most important prognostic factor affecting survival, 
but it is advanced around 75% of cases, especially in 
developing countries. As a result, about 40% to 60% of 
patients with SCC have locoregional recurrence and 
20% to 30% progress with distant metastases8. After 
treatment, the overall mortality rate stands at around 
40% to 60% in developed countries, with a global 
average around 46%9. The reasons described in the 
literature to justify this high incidence in advanced 
phases are distributed in a miscellany of situations: 
cultural and economic factors, poor social support, 
lifestyles, demographics and geographic factors, as 
well as difficulties in having access to healthcare10-13. 
There is no consensus in the literature regarding 
barriers to the early diagnosis of SCC.
Studies in Brazil show that the population is 
unaware of the risk factors associated with these 
cancers14,15. This is partially due to low levels of 
schooling and low household per capita income16,17. 
Another study suggests that the early diagnosis of SCC 
may be hampered by the fact that the initial lesions, 
with few symptoms, are not appreciated either by 
the individual or by healthcare workers12. They also 
suggest that these symptoms can be confused with 
other common diseases affecting the population. 
More so when these symptoms have never been 
presented to them as cancer harbingers18,19. Modern 
health thinking is based on the co-responsibility of 
the individual for his own health20.
In Brazil, there are selective campaign against 
oral cavity or laryngeal SCC and most of them have 
been highly ineffective, suggesting the need for fur-
ther understanding the biological and epidemiological 
processes behind these types of cancer15,16,21, hence 
the finding of a carcinogenic lesion remains the most 
effective clinical intervention22,23. In terms of research, 
much emphasis has been given to the risk factors and 
their causal relationships, and less has been done 
regarding its natural clinical history.
Finally, the disease remains challenging be-
cause of its diagnoses in advanced stages, its high 
morbimortality24 and hence the negative impact on 
budgets. There are very few correlational studies 
between the various symptoms, clinical staging and 
disease course vis-à-vis the initial diagnosis, since it 
may help to understand human behavior in different 
regions of the world and outline an epidemiological 
profile with specific health actions concerning the 
population exposed to certain risk factors.
SCCs may be considered as a separate disorder 
in the four anatomical sites and traditionally focused 
on the specialist’s view or be presented as a single 
disease25,26. In this approach, there is a strong increase 
in its incidence, taking into account similar epidemio-
logical aspects, and there may be a convergence of 
combined health actions with cost reduction - vision 
focused on public health. With both approaches, the 
present study has the “overall objective” to describe 
the sociodemographic, behavioral, and clinical charac-
teristics of the sample. The “secondary objectives” are 
to associate disease course with its staging in initial 
and advances stages, as well as establish the temporal 
relationship of the signs/symptoms with the patients’ 
general and nutritional status at the time of diagnosis.
METHOD
Historical Cohort Cross-Sectional Study - it 
follows the same characteristics of the longitudinal 
cohort study, however establishing a restricted time 
point (cut) to assess the elements studied, with no 
follow-up over time. For the study we selected 895 
patients with SCC, between March 1996 and January 
2009, seen at the head and neck surgery clinics loca-
ted in Montes Claros/Minas Gerais - Brazil. We used 
standard patient charts from only one specialist. This 
study was approved (Resolution 131 - CEPEX/2008, 
Ethics Board under protocol # 005/2008) and did not 
receive funding for its execution. The variables used 
are described below.
Sociodemographic variables (gender, marital 
status, age group, place of residence and occupation) 
and lifestyle habits harmful to health, such as smoking 
and drinking alcoholic beverages, in addition to the 
following clinical variables: anatomical sites and 
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subsites according to the International Classification 
of Diseases (ICD, 10th ed., 2000)27 as follows: oral 
cavity, oropharynx, larynx and hypopharynx. The 
criteria used for staging followed the TNM system 
of the International Union Against Cancer (IUAC 
TNM, 6th ed., 2002)28. Patients with diagnosis dates 
prior to 2002 had their staging updated under current 
TNM standards. Disease progression was considered 
as reported by the patient, between the dates of 
the first symptoms to the first visit to a specialist in 
head and neck surgery (short: ≤ 3 months; long: > 3 
months). Nutritional status was assessed according 
to a subjective global assessment of the nutritional 
state29,30 considering the patient’s report of weight 
loss, current weight of the patient, the medical and 
physical characteristics presented by the patient or by 
the association of this information. The general health 
was assessed by the clinical classification from the 
Zubrod-Karnofsk31 Performance Status assessment.
We calculated the frequencies, mean values 
and odds ratios for possible associations between 
the variables investigated. We used the Statistical 
Package for Social Sciences (SPSS V. 19®). Initially, 
we performed a descriptive analysis of the data. 
Subsequently, due to the nature of the variables, 
we used the nonparametric tests, a bivariate analysis 
(χ2 test, Mann-Whitney test) and multivariate data 
analysis (binary logistic regression). The significance 
level of 5% was retained for the statistical procedures 
performed (p = 0.05*).
RESULTS
The conditions most frequently encountered 
were: males (84.8 %) in the ratio of 5.6 ♂ : 1 ♀. 
Age ranged from 7 to 92 years, with a mean value 
of 59.6 years and incidence peaks between the 5th 
(28.6 %) and 6th (24.8 %) decades of life. We found 
a higher number of smokers/former smokers (91.5 
%) and alcoholic beverages drinkers/former drinkers 
(86.4 %). As for skin color, the distribution was as 
follows: whites 227 (30.6 %), browns 417 (56.1 %) 
and blacks 99 (13.3%). Regarding marital status, mar-
ried subjects represented 64.8 % (449), singles 17.3% 
(120), widow (er) 12 % (83), separated 4% (28) and 
1.9% others (13).
The anatomical sites affected were distributed 
as follows: oral cavity (33.9%), larynx (28.8%), oro-
pharynx (27.9%), and hypopharynx (9.4%) - Table 1. 
On this table one can also notice the most affected 
subsites. Considering all the anatomical sites, clinical 
staging upon diagnosis was advanced in 80.5% of 
patients. The anatomic site at which the disease was 
most advanced in stages III/IV was the hypopharynx 
with 96.3 % - Table 1.
Considering the nutritional status, 52.1 % of 
the patients were emaciated or malnourished upon 
diagnosis and, as far as general condition is concer-
ned, 55.9 % had mild to moderate impact - Table 1.
Symptoms were observed in two ways: 
separately, for each anatomical site and together - 
SCC being considered here as a single disease. In the 
former, and as expected, the most frequent symptoms 
were distributed in different ways for each anatomic 
site. The three main symptoms in order of frequency 
for the oral cavity were: pain, lesion reported by the 
patient and earache. The oropharynx had the follo-
wing distribution of symptoms: pain, dysphagia and 
odynophagia. For the larynx, they were: dysphonia, 
pain and dyspnea, and for the hypopharynx: pain, 
dysphagia and dysphonia.
Otherwise, upon considering all anatomical si-
tes together, some differences are noteworthy and the 
most prevalent symptom of the sample is represented 
by tumor pain (71.5 %); followed by reflex otalgia, 
dysphonia, dysphagia, reporting the lesion - the pa-
tient reporting a neck lump and dyspnea - Table 1.
After considering the differences in clinical 
behavior (signs and symptoms) of UADT SCC obtai-
ned by separate and joint evaluation of anatomical 
sites, one can notice their association with the initial 
and advanced staging.
Considering again the anatomic sites separately 
through a multivariate logistic regression between 
staging, anatomical site and symptoms, the results 
show statistically significant associations for advan-
ced disease. They were statistically significant in the 
oral cavity, pain and injury reported by the patient; 
in the oropharynx, the reporting of a lump by the 
patient, otalgia and drooling; in the larynx: dyspho-
nia, hawking and dyspnea; and in the hypopharynx: 
dysphonia, dysphagia, patient reporting a lump and 
a foreign body sensation - Table 2.
Considering now the anatomical sites together, 
through the distribution of symptoms according to 
staging, we obtained statistically significant associa-
tions between symptoms and advanced stage, these 
being: the report of the nodule, otalgia, dysphagia, 
dyspnea and the account of a lesion - Table 3.
We found statistically significant associations 
between staging in advanced stages of the disease with 
the general and nutritional status variables - Table 4.
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Table 1. Distribution and frequency of patients with UADT SCC by anatomical site, according to staging (cTNM), general health, 
nutritional status and symptoms.
Clinical variables Oral cav. Oropharynx Larynx Hypopharynx n (%) Total
Staging n (%) n (%) n (%) n (%) %
0/I Initial 27 (15.3) 1 (0.4) 35 9 (13.9) 1 (1.2) (0/I/II)
II 59 (19.6) 18 (7.4) 33 (13.1) 2 (1.8) = 19.5
III Advanced 69 (27.1) 64 (26.4) 105 (41.7) 17 (20.7) (III/IV)
IV 146 (32.7) 159 (65.7) 79 (31.3) 62 (75.6) = 80.5
Total 1 301 242 252 82 877 (100%)
General health status n (%)
90-100% 93 (31.8) 56 (23.7) 72 (30.8) 12 (15.0) 233 (27.7)
70-80% 162 (55.5) 130 (55.1) 133 (56.8) 46 (57.5) 471 (55.9)
50-60% 35 (12.0) 44 (18.6) 22 (9.4) 15 (18.8) 116 (13.8)
30-40% 0 4 (1.7) 3 (1.3) 7 (8.8) 14 (1.7)
0-20% 2 (0.7) 2 (0.8) 4 (1.7) 0 8 (0.9)
Total 2 292 236 234 80 842 (100)
Nutritional status n (%)
Nourished 154 (53.5) 88 (37.3) 130 (55.8) 41 (51.3) 413 (49.3)
Emaciated 122 (42.4) 132 (55.9) 96 (41.2) 34 (42.5) 384 (45.9)
Malnourished 12 (4.4) 16 (6.8) 7 (3.0) 5 (6.3) 40 (4.8)
Total 3 288 236 233 80 837 (100)
Symptoms N
Dysphonia 16 (5.9) 51 (22.4) 175 (77.8) 45 (57.0) 287
Dyspnea 2 (0.7) 21 (9.20) 69 (30.7) 17 (21.5) 109
Dysphagia 42 (15.5) 70 (30.7) 53 (23.6) 45 (57.0) 210
Pain 211 (77.9) 195 (85.0) 104 (46.6) 64 (81.0) 574
Emaciation report 28 (10.3) 25 (11.0) 15 (6.7) 15 (19.0) 83
Lesion report 135 (49.8) 34 (14.9) 7 (3.1) 0 176
Neck nodule report 45 (16.6) 68 (29.8) 28 (12.4) 22 (27.8) 163
Otalgia 162 (37.6) 108 (47.4) 45 (20.0) 32 (40.5) 347
Sensation foreign body 3 (1.1) 23 (10.1) 16 (7.1) 10 (12.7) 52
Pasty voice 14 (5.2) 17 (7.5) 1 (0.4) 1 (1.3) 33
Sorethroat 24 (8.9) 70 (30.7) 26 (11.6) 23 (29.1) 143
Coughing 2 (0.7) 6 (2.6) 14 (6.2) 3 (3.8) 25
Hawking 0 3 (1.3) 12 (5.3) 2 (2.5) 17
Halitosis 4 (1.1) 8 (3.5) 1 (0.4) 0 13
Trismus 11 (4.0) 6 (2.6) 0 1 (1.3) 18
Drooling 3 (1.1) 4 (3.1) 1 (0.4) 0 8
Bleeding 14 (5.2) 6 (2.6) 8 (3.6) 2 (2.5) 30
We found no association between disease 
course and its staging. There was no statistically sig-
nificant difference between disease course and the 
initial or advanced stages. Unlike hypothesized (H
1
), 
the disease course did not correlate with staging; ho-
wever, the long disease course (over three months) 
was correlated with worsening nutritional states and 
general health of the patients - Table 5. The time of 
complaints reported by patients (n = 778) ranged from 
1 to 60 months (30 to 1,800 days), with an average 
of 150 days (SD = 235.44).
One can observe the variables that correlate 
with worsening patient nutritional status, such as 
dyspnea, dysphagia, weight loss reported by the 
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Table 3. Distribution of variables: symptoms of patients with UADT SCC, according to staging. Odds Ratio (OR - odds ratio) with 
a confidence interval of 95% (CI).
Symptom
Staging
Total OR
pAdvanced III/IV Initial 0/I/II
n (%) n (%) n (100%) (IC-95%)
Dysphagia
Yes 195 (30.6) 13 (8.6) 208 2.6 (1.4-5.0) 0.004*
No 442 (69.4) 138 (91.4) 580 1.0
Dysphonia
Yes 218 (34.2) 60 (39.7) 278 0.69 (0.4-0.2) 0.18
No 419 (65.8) 91 (60.3) 510 1.0
Dyspnea
Yes 91 (86.7) 14 (9.3) 105 2.2 (1.1-4.3) 0.027*
No 546 (85.7) 137 (90.7) 683 1.0
Pain
Yes 492 (77.2) 76 (50.3) 568 1.62 (1.0-0.6) 0.052
No 145 (22.8) 75 (49.7) 220 1.0
Emaciation report
Yes 77 (12.1) 4 (2.6) 81 2.8 (1.0-8.2) 0.059
No 560 (87.9) 147 (97.4) 707 1.0
Lesion report
Yes 120 (18.8) 52 (34.4) 172 2.15 (0.3-0.9) 0.021*
No 517 (81.2) 99 (65.6) 616 1.0
Lump report
Yes 156 (24.5) 6 (4.0) 162 7.6 (3.2-18.1) 0.000*
No 481 (75.5) 145 (96) 626 1.0
Otalgia
Yes 266 (41.8) 21 (13.9) 287 2.6 (1.5-4.6) 0.001*
No 371 (58.2) 130 (86.1) 501 1.0
Foreign body
Yes 41 (6.4) 9 (6) 50 0.95 (0.4-2.2) 0.91
No 569 (93.6) 142 (94.0) 738 1.0
Pasty voice
Yes 31 (4.9) 2 (1.3) 33 1.4 (0.3-6.6) 0.69
No 606 (95.1) 149 (98.7) 755 1.0
Odinophagia
Yes 134 (21.0) 8 (5.3) 142 2.1 (0.9-4.7) 0.087
No 503 (79.0) 143 (94.7) 649 1.0
patient, otalgia and trismus. Similarly, the nutritio-
nal status variable correlated with general health 
worsening. Now, ‘dysphagia and dyspnoea’ were 
statistically significant vis-à-vis the worsening in their 
general health - Table 6.
DISCUSSION
In this study, the epidemiological profile 
of the UADT SCC patients was similar to findings 
published in the literature32-34. The significant findings 
regarding gender 5.6 ♂ : 1 ♀ , are partly justified by 
sociocultural factors; men being more exposed to 
carcinogenic agents for the development of UADT 
SCC (risk factors: tobacco and alcohol). The advanced 
stage found in 80.5% of patients did not differ 
from the literature33,34 but confirms the seriousness 
regarding the epidemiology of UADT SCC.
Pain, in its various forms, was the most 
prevalent general symptom, affecting 71.5 % of 
patients with UADT SCC, possibly due to the high 
Table 2. The association of UADT SCC patient symptoms 
variables, according to anatomical site and stage, estimated 
by the multivariate logistic regression model. Odds Ratio (OR) 
with a 95% confidence interval (IC).
Anatomical 
site Symptoms OR (CI 95%) p-value
Model 1: 
Oral cavity
Pain 1.64 (0.02-0.44) 0.047*
Reporting the lesion 5.87 (1.01-2.68) 0.000*
Model 2: 
Oropharynx
Reporting the lump 1.80 (1.22-2.63) 0.003*
Otalgia 1.61 (1.14-2.26) 0.006*
Odinophagia 2.65 (1.78-3.96) 0.000*
Drooling 4.94(1.35-18.05) 0.016
Model 3: 
Larynx
Dysphonia 8.06(5.15-12.62) 0.000*
Dyspnea 2.04 (1.19-3.50) 0.009*
Hawking 4.53(1.15-17.85) 0.031
Model 4: 
Hypopharynx
Dysphonia 2.26 (1.37-3.71) 0.001*
Dysphagia 4.24 (2.59-6.95) 0.000*
Reporting of a lump 1.81 (1.03-3.17) 0.038*
Foreign body 2.50 (1.14-5.45) 0.022*
* p-value < 0.05.
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Coughing
Yes 19 (3.0) 5 (3.3) 24 0.81 (0.3-2.6) 0.72
No 618 (97) 146 (96.7) 764 1.0
Hawking
Yes 8 (1.3) 7 (4.6) 15 0.31 (0.9-1.0) 57
No 773 (98.1) 144 (95.4) 917 1.0
Bleeding
Yes 19 (3.0) 10 (6.6) 29 0.55 (0.2-1.3) 0.18
No 618 (97.0) 141 (93.4) 759 1.0
Continued Table 3.
* p-value < 0.05.
number of patients with advanced disease, similar 
to that of another study35. It is known that pain 
increases the degree of suffering of patients, with 
significant reduction in hours of sleep, leading 
to drops in productive capacity, absenteeism and 
money spent with medications, which ended in a 
Via Crucis for social support and medical care. This 
fact shows the importance of pain as a recognition 
factor of the state of sickness of UADT SCC patients19, 
but this, unfortunately, already predicts advanced 
disease. Such as pain, many signs and symptoms 
are associated with advanced disease in a statistically 
significant fashion, which does not favor prognosis.
The UADT SCC, which was evaluated by 
two approaches, as different diseases or as a single 
disease, presented somewhat similar information. 
The former had heterogeneous symptoms, which 
is unevenly distributed among the four anatomical 
sites, but did not show any pathognomonic sign or 
symptom to either location. Although the anatomical 
Table 6. Association between the general health and nutritional 
status of UADT SCC patients with symptoms*; estimated by 
the binary logistic regression model. Odds Ratio (OR) with a 
95% confidence interval (CI).
General 
health OR (CI 95%) p
Symptoms
Dyspnea Yes 2.33 (1.39-3.88) 0.001*
No 1.0
Dysphagia
Yes 1.93 (1.26-2.95) 0.003*
No 1.0
Nutritional status
Symptoms
Dyspnea
Yes 2.41 (1.52-3.82) 0.000*
No 1.0
Dysphagia
Yes 2.66 (1.85-3.84) 0.000*
No 1.0
R.Emanc.
Yes 3.24 (1.82-5.77) 0.000*
No 1.0
Otalgia
Yes 1.63 (1.19-2.25) 0.003*
No 1.0
Trismus
Yes 3.74 (1.19-11.80) 0.025*
No 1.0
* We considered here only those variables with statistically significant 
results. * p-value < 0.05.
sites are distinct and have different functions together, 
their anatomical proximity can make large tumors 
involve more than one anatomical site or subsite 
simultaneously, thus producing mixed symptoms. The 
symptoms listed here were associated with advanced 
disease. The UADT SCC evaluated as a single disease 
Table 4. Distribution of variables: general and nutritional status of patients with UADT SCC as per staging and binary logistic 
regression analysis. Odds Ratio (OR) with a confidence interval of 95% (CI).
Variable
Staging
Total OR
pAdvanced Initial
n (%) n (%) n (CI-95%)
General health
Compromized 129 (19.6) 5 (3.1) 134 7.7 (3.0-19.0) 0.000*
Preserved 530 (80.4) 157 (96.9) 687 1.0
Nutritional status
Emaciated or malnourished 388 (58.9) 41 (25.2) 429 4.2 (2.9-6.3) 0.000*
Nourished 271 (41.1) 122 (74.8) 393 1.0
* p-value < 0.05.
Table 5. Descriptive measure (mean rank) of disease course 
according to staging, patient's general condition and nutritional 
status, and the Mann-Whitney test.
Course 
(months) Staging General health
Nutritional 
status
n (mean rank) n (mean rank) n (mean rank)
≤ 3 months 251 (364.95) 250 (361.00) 250 (350.23)
> 3 months 493 (376.34) 500 (382.75) 501 (388.86)
p 315 0.043* 0.008**
* p-value < 0.05.
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had symptoms associated with advanced disease 
such as reporting of the lump, dysphagia, reports of 
a lesion and dyspnea.
It is difficult to understand why UADT SCC 
is not diagnosed at an initial stage, but the various 
symptoms were mostly associated to an advanced 
stage. Possibly, the initial symptoms are subtle, 
disregarded by the patient and the disease evolves 
progressively and rapidly to the advanced stage, not 
yielding to an initial diagnosis in proper time19.
However, the population has no knowledge 
or clinical conditions to identify initial or precance-
rous UADT SCC lesions12,19,23, a finding essential to 
prevention. The active search for precursor UADT 
SCC lesions (screening) should be reconsidered for 
individuals with risk factors for its development (over 
45 years old, smoker and/or drinker), as already 
observed in other studies with favorable results35-37. 
There is a range of medical equipment currently avai-
lable to perform imaging of the upper aerodigestive 
tract (laryngoscopy), which can be offered to the 
community by the public healthcare system; howe-
ver, at a cost to be assessed. Primary and secondary 
care require investments in physical infrastructure 
and technology for proper action in the prevention 
and early diagnosis of UADT SCC, as it was done for 
cervix cancer38.
Some symptoms were significantly associated 
with the physical decline of patients, such as dysp-
nea, dysphagia and weight loss. Individuals with 
mechanical constraints for breathing and/or feeding, 
due to tumor invasion, have their nutritional status 
compromised39. These symptoms may be the ones 
most associated with the wasting state of the disease 
and can have an unfavorable impact on treatment 
and prognosis.
The disease course between the first signs 
and symptoms until the patient’s motivation to seek 
medical care was long in this series (patient’s delay), 
around 150 days, but also comparable to results 
published in the literature40. The long disease course 
(> three months) correlated with worsening nutritional 
and general health status, similarly to that found by 
other studies, require these patients to receive greater 
attention in terms of clinical ad nutritional support41,42.
CONCLUSION
Among the results, two were really striking 
when considering UADT SCC as a single disease: 
(1) there were no statistically significant signs and 
symptoms of early UADT SCC, and (2) there was no 
correlation between the disease course and its staging 
(patient’s delay). This proved, and as the most im-
portant conclusion, that when the symptoms become 
noticeable to patients, they are already an indication 
of an abnormality, in fact already foreshadowing ad-
vanced disease, suggesting rapid evolution of early 
disease stage to more advanced stages.
The long course of UADT SCC - more than 
three months, can be regarded as a predictor of wor-
sening in the patient’s general and nutritional status. 
Similarly and specifically, symptoms of “dyspnea and 
dysphagia” joined the overall status of these patients.
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